FA
NTUS

Friess Associates’s Natus Medical Inc NTUS Stock Holding History

Friess Associates’s Portfolio NTUS Stock Details NTUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-21,850
Closed -$549K – 173
2014
Q2 		$549K Buy
21,850
+550
+3% +$13.6K 0.04% 91
2014
Q1 		$550K Buy
+21,300
New +$537K 0.04% 91

Other funds holding NTUS

EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Diamond Hill Capital Management
Diamond Hill Capital Management Columbus, Ohio $16B AUM 4.15% 1-Year Est. Return
CCM
Corsair Capital Management New York $673M AUM 109.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Friess Associates's NTUS Position: Q3 2014 in Review

Friess Associates sold out of Natus Medical Inc (NTUS) in Q3 2014, closing a stake of 21,850 shares — an estimated $549K sold.

Friess Associates first reported a position in NTUS in Q1 2014 and held it in 2 quarters. The position peaked at $550K in Q1 2014. 184 funds tracked by Wall St. Rank hold NTUS as of Q3 2014.

  • Friess Associates reported no remaining Natus Medical Inc position as of Q3 2014 after selling out during the quarter.
  • Friess Associates sold 21,850 Natus Medical Inc shares in Q3 2014, an estimated $549K.
  • Friess Associates first reported a position in Natus Medical Inc in Q1 2014 and held it in 2 quarters.
  • Friess Associates's Natus Medical Inc position peaked at $550K in Q1 2014.
  • 184 funds tracked by Wall St. Rank held Natus Medical Inc as of Q3 2014.

Based on Friess Associates's 13F filing for Q3 2014, filed 14 Nov 2014.